Additional Drug Resistance in Mycobacterium tuberculosis Isolates From Resected Cavities Among Patients With Multidrug-Resistant or Extensively Drug-Resistant Pulmonary Tuberculosis
Author(s) -
Russell R. Kempker,
Alexander S. Rabin,
Ketino Nikolaishvili,
Iagor Kalandadze,
Shota Gogishvili,
Henry M. Blumberg,
Sergo Vashakidze
Publication year - 2011
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/cir904
Subject(s) - medicine , tuberculosis , drug resistance , mycobacterium tuberculosis , sputum , multiple drug resistance , drug , extensively drug resistant tuberculosis , microbiology and biotechnology , pharmacology , pathology , biology
The pathogenesis of increasing drug resistance among patients with multidrug-resistant or extensively drug-resistant tuberculosis undergoing treatment is poorly understood. Increasing drug resistance found among Mycobacterium tuberculosis recovered from cavitary isolates compared with paired sputum isolates suggests pulmonary cavities may play a role in the development of worsening tuberculosis drug resistance.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom